1. Predictive model developed and validated for assessing seizure recurrence risk after discontinuation of antiseizure medication in pediatric epilepsy patients.
2. Model identified nine independent risk factors and demonstrated strong discriminatory performance.
3. Emphasized importance of individualized treatment planning and external validation across diverse clinical settings.
4. Recommended future longitudinal studies to assess long-term predictive accuracy and explore additional influencing variables.

Source: eClinicalMedicine